文献
J-GLOBAL ID:201802267294276503
整理番号:18A1195655
攻撃性成人T細胞白血病リンパ腫患者におけるモガムリズマブの移植前および移植後の使用:日本における重要な意見リーダーからの声明【JST・京大機械翻訳】
Pre- and posttransplant use of mogamulizumab in patients with aggressive adult T-cell leukemia-lymphoma: A statement from key opinion leaders in Japan
著者 (9件):
Fuji Shigeo
(Department of Hematology, Osaka International Cancer Institute, Osaka, Japan)
,
Kato Koji
(Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan)
,
Nakano Nobuaki
(Department of Hematology, Imamura General Hospital, Kagoshima, Japan)
,
Ishida Takashi
(Department of Hematology and Oncology, School of Medical Sciences, Nagoya City University Graduate, Nagoya, Japan)
,
Ishida Takashi
(Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Iwate, Japan)
,
Ishitsuka Kenji
(Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan)
,
Choi Ilseung
(Department of Hematology, National Hospital Kyushu Cancer Center, Fukuoka, Japan)
,
Matsuoka Ken-ichi
(Department of Hematology and Oncology, Okayama University, Okayama, Japan)
,
Utsunomiya Atae
(Department of Hematology, Imamura General Hospital, Kagoshima, Japan)
資料名:
Advances in Cell and Gene Therapy
(Advances in Cell and Gene Therapy)
巻:
1
号:
1
ページ:
e5
発行年:
2018年
JST資料番号:
W2681A
ISSN:
2573-8461
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)